📰 Ralph Niven News
Ralph Niven News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Ralph Niven. Real-time updates on events, politics, business and more.
April 24, 2024
Aerovate Therapeutics, Inc. (NASDAQ:AVTE – Get Free Report) shares saw strong trading volume on Wednesday . 197,194 shares traded hands during trading, an increase of 52% from the previous session’s volume of 129,738 shares.The stock last traded at $22.91 and had previously closed at $23.22. Wall Street Analysts Forecast Growth A number of research analysts […]
April 24, 2024
Aerovate Therapeutics, Inc. (NASDAQ:AVTE – Get Free Report) shares saw strong trading volume on Wednesday . 197,194 shares traded hands during trading, an increase of 52% from the previous session’s volume of 129,738 shares.The stock last traded at $22.91 and had previously closed at $23.22. Wall Street Analysts Forecast Growth A number of research analysts […]
April 1, 2024
Aerovate Therapeutics, Inc. (NASDAQ:AVTE – Get Free Report) hit a new 52-week high during trading on Monday . The company traded as high as $30.73 and last traded at $28.72, with a volume of 14079 shares. The stock had previously closed at $29.57. Analyst Upgrades and Downgrades A number of equities research analysts have recently […]
March 28, 2024
Jefferies Financial Group started coverage on shares of Aerovate Therapeutics (NASDAQ:AVTE – Free Report) in a research note issued to investors on Monday morning, Marketbeat.com reports. The firm issued a buy rating and a $65.00 price target on the stock. Separately, Wells Fargo & Company initiated coverage on shares of Aerovate Therapeutics in a research […]
March 26, 2024
Aerovate Therapeutics, Inc. (NASDAQ:AVTE – Get Free Report)’s share price fell 8.8% during mid-day trading on Tuesday . The company traded as low as $24.27 and last traded at $24.58. 36,947 shares were traded during mid-day trading, a decline of 63% from the average session volume of 100,754 shares. The stock had previously closed at […]
February 16, 2024
Aerovate Therapeutics, Inc. (NASDAQ:AVTE – Get Free Report) shares traded up 10.8% during mid-day trading on Thursday . The company traded as high as $21.34 and last traded at $21.32. 43,510 shares were traded during mid-day trading, a decline of 50% from the average session volume of 86,833 shares. The stock had previously closed at […]
February 8, 2024
Aerovate Therapeutics, Inc. (NASDAQ:AVTE – Get Free Report) insider Ralph Niven sold 4,600 shares of the company’s stock in a transaction on Monday, February 5th. The shares were sold at an average price of $17.45, for a total value of $80,270.00. Following the completion of the sale, the insider now owns 1,609 shares of the […]
August 15, 2023
Aerovate Therapeutics (NASDAQ:AVTE – Get Free Report)‘s stock had its “outperform” rating restated by equities research analysts at Wedbush in a research note issued to investors on Tuesday, RTT News reports. They presently have a $48.00 price objective on the stock, down from their prior price objective of $50.00. Wedbush’s price target suggests a potential […]
June 18, 2023
Aerovate Therapeutics, Inc. (NASDAQ:AVTE – Get Rating) was the recipient of a significant increase in short interest in the month of May. As of May 31st, there was short interest totalling 961,900 shares, an increase of 5.3% from the May 15th total of 913,900 shares. Based on an average trading volume of 78,000 shares, the […]
June 10, 2023
Aerovate Therapeutics, Inc. (NASDAQ:AVTE – Get Rating) insider Ralph Niven sold 2,250 shares of Aerovate Therapeutics stock in a transaction dated Monday, June 5th. The stock was sold at an average price of $16.26, for a total value of $36,585.00. Following the sale, the insider now directly owns 1,609 shares of the company’s stock, valued […]